Nec Oncoimmunity As

Nec Oncoimmunity As company information, Employees & Contact Information

NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.
Looking for a particular Nec Oncoimmunity As employee's phone or email?

Nec Oncoimmunity As Questions

News

NEC OncoImmunity to Present Developments in the Infectious Diseases at 21st AIFII2023 - NEC Global

NEC OncoImmunity to Present Developments in the Infectious Diseases at 21st AIFII2023 NEC Global

CEPI partners with Japan's NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine - CEPI

CEPI partners with Japan's NEC Group to develop artificial intelligence-designed broadly protective betacoronavirus vaccine CEPI

NEC acquires Norwegian bioinformatics company, OncoImmunity AS: Press Releases - NEC Global

NEC acquires Norwegian bioinformatics company, OncoImmunity AS: Press Releases NEC Global

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business - HPCwire

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business HPCwire

NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy - NTB Kommunikasjon

NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy NTB Kommunikasjon

NEC Acquires Bioinformatics Company OncoImmunity AS - FinSMEs

NEC Acquires Bioinformatics Company OncoImmunity AS FinSMEs

NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets: Press Releases - NEC Global

NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets: Press Releases NEC Global

NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS - NTB Kommunikasjon

NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS NTB Kommunikasjon

Top Nec Oncoimmunity As Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant